Bioactive components conjugated to substrates of microneedle arrays

Patent metadata

Field	Value
Publication number	US-11672964-B2
Application number	US-202016942669-A
Country	US
Kind code	B2
Filing date	Jul 29, 2020
Priority date	Mar 18, 2015
Publication date	Jun 13, 2023
Grant date	Jun 13, 2023

Abstract

Microneedle arrays and methods of forming the same can include one or more bioactive components bonded to a biocompatible material such that the one or more bioactive components are cleavable in vivo to release the bioactive component from the biocompatible material.

First claim

We claim:

1. A method of fabricating a microneedle array comprising:
applying a first solution of a dissoluble biocompatible material having one or more bioactive components conjugated to the dissoluble biocompatible material therein to a microneedle array production mold;
applying a second solution of the dissoluble biocompatible material that does not contain one or more active components to the microneedle array production mold; and
drying the first and second solutions to form a solid microneedle array that comprises a base portion and a plurality of microneedles that extend from the base portion, wherein the one or more active components are substantially concentrated in the plurality of microneedles,
wherein the one or more bioactive components are covalently bonded to the dissoluble biocompatible material and the conjugated bioactive components are cleavable in vivo to release the bioactive component from the biocompatible material,
wherein the one or more bioactive components are bonded to the biocompatible material by a disulfide bond.

2. The method of claim 1 , wherein the dissoluble biocompatible material is carboxymethylcellulose.

3. The method of claim 1 , wherein the at least two different bioactive components are selected from the group consisting of a chemotherapeutic agent, an adjuvant, and a chemo attractant for a cancer chemo immunotherapy application.

4. The method of claim 1 , wherein the one or more bioactive components comprise Doxorubicin.

5. The method of claim 1 , wherein the bioactive component comprises an antigen and an adjuvant for a vaccine application.

6. The method of claim 1 , wherein the one or more bioactive components of the first solution comprises at least one viral vector.

7. The method of claim 1 , wherein the first and second solution form a sheet array having a plurality of layers and the method further comprises removing portions from the sheet array until a microneedle array is formed having a base portion and plurality of microneedles extending from the base portion.

8. The method of claim 7 , wherein the removal of portions from the sheet array comprises forming the microneedle array so that the one or more bioactive component is concentrated in the respective microneedles of the microneedle array and the one or more bioactive components are substantially absent from the base portion.

9. The method of claim 8 , wherein the method of forming the sheet array comprises spatially distributing the at least one bioactive component across the sheet of material, and the act of removing portions from the sheet array comprises:
micromilling the sheet array to form a microneedle array, the microneedle array comprising a base portion and plurality of microneedles extending from the base portion, wherein the one or more bioactive component is concentrated in the respective microneedles of the microneedle array and the at least one bioactive components is substantially absent from the base portion.

Assignees

• Univ Of Pittsburgh—Of The Commonwealth System Of Higher Education

Inventors

• Falo Jr Louis D
• Erdos Geza

Classifications

• B29C39/025

  for making multilayered articles · CPC title

• A61M2037/0046

  Solid microneedles · CPC title

• B29L2031/7544

  Injection needles, syringes · CPC title

• B29C41/22

  Making multilayered or multicoloured articles · CPC title

• B29L2031/756

  Microarticles, nanoarticles · CPC title